Physician profile
Timothy Miller
NPI 1841566262
$102,203.36
in general payments reported to CMS, 2019-2025
47 companies · $4,077 in 2025
The $4,077 reported for 2025 was more than what 78% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,352 · 2020: $2,724 · 2021: $4,377 · 2022: $16K · 2023: $18K · 2024: $53K · 2025: $4,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Travel and Lodging: $7,572 · Food and Beverage: $6,916 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,500.00 |
| Travel and Lodging | $7,571.94 |
| Food and Beverage | $6,915.65 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $83,531.43 | 2021-2025 | Mazor X System, Unid_pass, Plasmablade(Tm) |
| Abbott Laboratories | $5,612.55 | 2019-2025 | Eterna, Proclaim |
| Mml US, INC. | $2,746.11 | 2022-2025 | Reactiv8 |
| Saluda Medical Americas, INC. | $2,323.94 | 2023 | Evoke Scs |
| Nuvasive, INC. | $1,527.40 | 2019-2023 | Alif, Xlif |
| Depuy Synthes Sales INC. | $885.30 | 2019-2020 | |
| Medical Device Business Services, INC. | $758.26 | 2019 | |
| Globus Medical, INC. | $514.21 | 2024-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Baxter Healthcare | $415.36 | 2021-2025 | Floseal, Perclot |
| Spineology INC. | $360.76 | 2021-2022 | |
| Medtronic USA, INC. | $321.97 | 2019-2020 | |
| Convatec INC. | $293.98 | 2024-2025 | |
| Insightec,INC | $283.94 | 2023-2025 | Exablate |
| Monteris Medical Corporation | $265.42 | 2022-2023 | Neuroblate |
| Brainlab, INC. | $224.03 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $209.16 | 2019-2022 | |
| Carlsmed, INC. | $182.12 | 2022-2023 | Aprevo |
| Cerapedics INC. | $180.51 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Osteomed LLC | $174.96 | 2021-2022 | |
| Abbvie INC. | $151.46 | 2023-2025 | |
| Zap Surgical Systems, INC. | $136.30 | 2022 | |
| Vertiflex, INC. | $135.11 | 2019 | |
| Nevro Corp. | $124.11 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.88 | 2023 | Xifaxan |
| Emd Serono, INC. | $91.08 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $76.43 | 2020-2021 | |
| Integra Lifesciences Corporation | $65.56 | 2019-2023 | Codman Hakim, Duraseal Exact Spinal Sealant System, Cusa Clarity |
| Boston Scientific Corporation | $56.78 | 2019-2022 | |
| Neuropace, INC. | $49.38 | 2024 | |
| Orthofix Medical, INC. | $39.40 | 2021 | |
| Lundbeck LLC | $35.00 | 2019 | |
| Celgene Corporation | $33.23 | 2022-2023 | Zeposia |
| Akcea Therapeutics, INC. | $33.06 | 2020 | |
| Omniscient Neurotechnology America LTD | $26.19 | 2023 | Quicktome |
| Spinal Elements, INC. | $24.76 | 2024 | |
| Greenwich Biosciences, INC. | $23.75 | 2021 | |
| Prosidyan, INC | $21.92 | 2019 | |
| Becton, Dickinson and Company | $21.36 | 2021 | |
| Icotec Medical INC. | $20.98 | 2023 | Icotec Blackarmor Spine System |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Tg Therapeutics, INC. | $19.83 | 2025 | |
| Vertos Medical, INC. | $17.97 | 2024 | Mild Device Kit |
| Nalu Medical, INC. | $17.67 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.65 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.92 | 2024 | Xarelto |
| Lilly USA, LLC | $14.17 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,327.46 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.